AHA: Lasting Benefit for CABG in Diabetes, Multivessel Disease
THURSDAY, Nov. 15, 2018 -- For patients with diabetes mellitus (DM) with multivessel coronary disease (MVD), coronary revascularization with coronary artery bypass grafting (CABG) is associated with lower all-cause mortality than percutaneous...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Coronary Artery Bypass Graft | Diabetes | Diabetes Mellitus | Endocrinology | Pharmaceuticals